Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Accumulated Expenses (2016 - 2026)

Dexcom has reported Accumulated Expenses over the past 17 years, most recently at $121.8 million for Q1 2026.

  • Quarterly Accumulated Expenses rose 9.93% to $121.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $121.8 million through Mar 2026, up 9.93% year-over-year, with the annual reading at $169.2 million for FY2025, 51.07% up from the prior year.
  • Accumulated Expenses was $121.8 million for Q1 2026 at Dexcom, down from $169.2 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $171.0 million in Q4 2023 and troughed at $84.7 million in Q1 2022.
  • The 5-year median for Accumulated Expenses is $112.7 million (2022), against an average of $123.4 million.
  • Year-over-year, Accumulated Expenses plummeted 34.5% in 2024 and then soared 60.87% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $134.3 million in 2022, then increased by 27.33% to $171.0 million in 2023, then plummeted by 34.5% to $112.0 million in 2024, then skyrocketed by 51.07% to $169.2 million in 2025, then fell by 28.01% to $121.8 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Accumulated Expenses are $121.8 million (Q1 2026), $169.2 million (Q4 2025), and $170.2 million (Q3 2025).